Aprea Therapeutics, Inc. — SCHEDULE 13G/A Filings
9 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 9 SCHEDULE 13G/A documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-26-015324 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001493152-26-003971 | Jan 28, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016261 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-011953 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000329 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-005582 | Apr 8, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000128 | Feb 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-002306 | Feb 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-005550 | Feb 10, 2025 | — |